Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
Portfolio Pulse from
Veru Inc. has sold its FC2 Female Condom business to Riva Ridge Capital Management LP and co-investors for $18 million. This divestiture allows Veru to focus on its core biopharmaceutical operations.
December 31, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Veru Inc. has divested its FC2 Female Condom business for $18 million, allowing the company to concentrate on its core biopharmaceutical operations.
The sale of the FC2 Female Condom business for $18 million provides Veru with additional capital and allows it to focus on its primary biopharmaceutical operations. This strategic move is likely to be viewed positively by investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100